Stay updated on PEMSYS: Pembrolizumab Modulation Clinical Trial

Sign up to get notified when there's something new on the PEMSYS: Pembrolizumab Modulation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PEMSYS: Pembrolizumab Modulation Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    - Revision updated from v3.3.3 to v3.3.4; no changes to the study data, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-01-14T03:03:18.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Footer updates: added Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2 notice. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T20:36:13.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Revision v3.3.2 has been added and v3.2.0 has been removed.
    Difference
    0.1%
    Check dated 2025-11-25T11:12:46.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Removed the government funding operating status notice/banner from the page. The study details and eligibility criteria remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-18T06:59:42.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The screenshots reflect only minor visual/layout updates and no changes to the study data, eligibility criteria, or primary outcomes.
    Difference
    0.5%
    Check dated 2025-11-03T21:07:35.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    - Updated operating status notice with funding lapse and links to official sources. - Bump version from v3.1.0 to v3.2.0.
    Difference
    4%
    Check dated 2025-10-06T05:37:07.000Z thumbnail image

Stay in the know with updates to PEMSYS: Pembrolizumab Modulation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PEMSYS: Pembrolizumab Modulation Clinical Trial page.